Jeffrey Albers Blueprint Medicines Corp

As of May 18, 2022


Jeffrey Albers Net Worth

  • Net worth is estimated to be at least $48.22M
  • Owns at least 183,243 units of Blueprint Medicines Corp stock
  • Sold an estimated value of $40.73M in the last 7 years at Blueprint Medicines Corp

Jeffrey Albers Compensation at Blueprint Medicines Corp in 2020

  • Earned a $645,000 salary
  • Received a total compensation of $6,344,667

Jeffrey Albers Trading

  • Largest purchase of shares was 30,000 units , worth over $351.75K on November 17, 2021
  • Largest sale of shares was 30,000 units , worth over $3.44M on November 17, 2021
  • In total has made about 43 transactions over 7 years
  • Usually trades in March, with the busiest year in 2020
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Jeffrey Albers Mailing Address

  • Mailing address is Blueprint Medicines Corp. 215 First Street, Suite 340/350 Cambridge MA 02142 MA

Blueprint Medicines Corp Executive Compensation

Name
Year
Salary
Total
Jeffrey W. Albers 2020 $645,000 $6,344,667
Jeffrey W. Albers 2019 $590,000 $9,362,371
Jeffrey W. Albers 2018 $541,144 $9,740,799
Michael Landsittel 2020 $379,575 $2,014,974
Michael Landsittel 2019 $345,000 $1,958,720
Michael Landsittel 2018 $281,678 $1,740,610
Fouad Namouni, M.D. 2020 $186,154 $6,668,732
Fouad Namouni, M.D. 2019 - -
Fouad Namouni, M.D. 2018 - -
Kathryn Haviland 2020 $460,944 $2,363,556
Kathryn Haviland 2019 $431,830 $3,090,423
Kathryn Haviland 2018 $392,589 $2,601,762
Tracey L. McCain, Esq. 2020 $453,301 $2,346,428
Tracey L. McCain, Esq. 2019 $437,972 $2,900,568
Tracey L. McCain, Esq. 2018 $425,216 $2,647,962
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1597264/000155837021004557/tmb-20210602xdef14a.htm

Blueprint Medicines Corp Insider Trading

  • The most recent transaction was 20,000 units sold on May 18, 2022 by Jeffrey Albers worth over $1.12M
  • In the last 7 years, insiders at Blueprint Medicines Corp sold an estimated value of $168.66M and bought an estimated value of $16.74M
  • The most active traders are Jeffrey Albers,  Ariel Hurley, PRINCIPAL ACCOUNTING OFFICER,  and Kate Haviland, CHIEF OPERATING OFFICER
  • Insider trading is most common in March, with the busiest year in 2020

Blueprint Medicines Corp Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1